💊

Drugs Recalls

Prescription and over-the-counter medications

17,685 Total Recalls

Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.

Apr 29, 2014 Other Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.

Apr 29, 2014 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling indicates it is to be used for the treatment of disease.

Apr 29, 2014 Prescription Drugs Nationwide View Details →

This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Jan 13, 2014 Prescription Drugs Nationwide View Details →

This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Jan 13, 2014 Prescription Drugs Nationwide View Details →

This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Jan 13, 2014 Prescription Drugs Nationwide View Details →

Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Jan 13, 2014 Prescription Drugs Nationwide View Details →